These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 2462973)

  • 41. An enzyme-immunoassay for antibodies against hepatitis B core antigen: characteristics and clinical validation.
    Matthyssen L; Arndt-Hanser A; Lange W; Maass G; Schütt K; van Loon A; Wolters G
    J Virol Methods; 1987 Aug; 17(1-2):95-103. PubMed ID: 3312270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can anti-HBc testing decrease the residual risk of transfusion-related HIV transmission?
    Fiedler H
    Vox Sang; 1991; 61(2):144-5. PubMed ID: 1763501
    [No Abstract]   [Full Text] [Related]  

  • 43. Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen.
    Caspari G; Beyer HJ; Elbert G; Koerner K; Muss P; Schunter FW; Uy A; Gerlich W; Thomssen R; Schmitt H
    J Clin Microbiol; 1989 Sep; 27(9):2067-72. PubMed ID: 2674199
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antibodies to hepatitis B core antigen and the infectivity of the blood supply. Scientific Section Coordinating Committee.
    Dodd RY; Popovsky MA
    Transfusion; 1991 Jun; 31(5):443-9. PubMed ID: 2048182
    [No Abstract]   [Full Text] [Related]  

  • 45. Specificity of enzyme immunoassay for hepatitis B core antibody used in screening blood donors.
    Barbara J; Contreras M
    Transfusion; 1988; 28(1):84. PubMed ID: 3277321
    [No Abstract]   [Full Text] [Related]  

  • 46. Infectious disease testing for blood transfusions.
    NIH Consens Statement; 1995 Jan 9-11; 13(1):1-27. PubMed ID: 7581534
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Isolated antibody to hepatitis B core antigen in blood donors and immune response to hepatitis B vaccination.
    Davis AR; Pink JM; Lien AH; Wylie BR
    Aust N Z J Med; 1993 Apr; 23(2):215. PubMed ID: 8357392
    [No Abstract]   [Full Text] [Related]  

  • 48. FDA and surrogate testing for non-A,non-B hepatitis.
    Biswas R
    Transfusion; 1989 Oct; 29(8):750. PubMed ID: 2508278
    [No Abstract]   [Full Text] [Related]  

  • 49. Isolated antibody to hepatitis B core is associated with hepatitis C virus co-infection.
    Greub G; Frei PC
    Clin Microbiol Infect; 2000 Nov; 6(11):629. PubMed ID: 11168071
    [No Abstract]   [Full Text] [Related]  

  • 50. DNA polymerase activity: a method of determining the infectivity of blood positive for anti-HBc.
    Ton SH; Lopez CG; Hasnah H
    Malays J Pathol; 1979 Aug; 2():53-7. PubMed ID: 263422
    [No Abstract]   [Full Text] [Related]  

  • 51. Anti-HBc testing alone not a reliable blood donor screen.
    Barbara JA; Tedder RS; Briggs M
    Lancet; 1984 Feb; 1(8372):346. PubMed ID: 6141414
    [No Abstract]   [Full Text] [Related]  

  • 52. [Serum levels of alanine aminotransferase and anti-HBc antibodies in blood donors: analysis of a group of 5000 donors from the Lorraine region].
    Janot C; Aymard JP; Petegnief P; Schooneman F; Legras B; Monange G; Streiff F
    Rev Fr Transfus Hemobiol; 1989 Feb; 32(1):69-72. PubMed ID: 2719779
    [No Abstract]   [Full Text] [Related]  

  • 53. Does blood with antibodies against hepatitis B carry an increased risk to transmit hepatitis.
    Vox Sang; 1975; 28(6):460-7. PubMed ID: 1146274
    [No Abstract]   [Full Text] [Related]  

  • 54. [Discussion comment on the paper by K.H. Meaer zum Büschenfelde and J.P.Bolte: Risk of hepatitis caused by blood and blood products and possibilities of hepatitis prevention, (this J. 15, 471-478(1974))].
    Internist (Berl); 1975 Sep; 16(9):444-5. PubMed ID: 1102481
    [No Abstract]   [Full Text] [Related]  

  • 55. On Trojan horses and surrogate mothers.
    Kolins J
    N Engl J Med; 1984 Jul; 311(1):53-4. PubMed ID: 6727967
    [No Abstract]   [Full Text] [Related]  

  • 56. Is screening of blood donors for anti-HBc useful?
    Caspari G; Beyer HJ; Schmitt H; Gerlich W; Uy A; Thomssen R
    Blut; 1990 Jun; 60(6):352-3. PubMed ID: 2375966
    [No Abstract]   [Full Text] [Related]  

  • 57. Organization of a blood transfusion service in tropical areas.
    Lopez CG
    Southeast Asian J Trop Med Public Health; 1979 Jun; 10(2):177-83. PubMed ID: 524138
    [No Abstract]   [Full Text] [Related]  

  • 58. IgA deficiency in Sydney blood donors and biological false reactivity in a hepatitis B surface antigen enzyme immunoassay.
    Davis AR; Pepper RP; Nelson M; Kenrick KG; Zarkos K
    Aust N Z J Med; 1995 Dec; 25(6):738. PubMed ID: 8770341
    [No Abstract]   [Full Text] [Related]  

  • 59. Possible role of immune responses to hepatitis B core antigen in protection against hepatitis B infections.
    Tabor E; Gerety RJ
    Lancet; 1984 Jan; 1(8369):172. PubMed ID: 6140488
    [No Abstract]   [Full Text] [Related]  

  • 60. Deleterious effect of sodium azide on the activity of peroxidase.
    Chaudhary RK; Parker C
    J Clin Pathol; 1983 Oct; 36(10):1201-2. PubMed ID: 6352746
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.